- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05867927
GENERATE - Next GENERATion of GynEcological Surgery - Cirugía asistida por robot en indicaciones ginecológicas (GENERATE)
GENERATE - Next GENERATion of GynEcological Surgery - Cirugía asistida por robot en indicaciones ginecológicas - Un estudio clínico prospectivo, no intervencionista, multicéntrico y posterior a la comercialización
GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications
Generate real-world evidence in the use of the da Vinci Surgical Systems for gynecological indications within the German health care system.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
A prospective, non-interventional, multi-center, post market clinical study.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Petra Kremer
- Número de teléfono: +49 151 62679136
- Correo electrónico: petra.kremer@intusurg.com
Copia de seguridad de contactos de estudio
- Nombre: Peter Appenrodt
- Número de teléfono: +49 173 2043740
- Correo electrónico: peter.appenrodt@intusurg.com
Ubicaciones de estudio
-
-
-
Berlin, Alemania, 13353
- Activo, no reclutando
- Charité - Universitätsmedizin Berlin - Klinik für Gynäkologie
-
Bochum, Alemania, 44791
- Activo, no reclutando
- Augusta-Kranken-Anstalt Bochum
-
Coburg, Alemania, 96450
- Activo, no reclutando
- Sana Kliniken Coburg
-
Cologne, Alemania, 50935
- Terminado
- St. Elisabeth-Krankenhaus Köln-Hohenlind
-
Essen, Alemania, 45147
- Activo, no reclutando
- Universitätsklinikum Essen
-
Frankfurt am Main, Alemania, 60431
- Activo, no reclutando
- Agaplesion Markus Krankenhaus Frankfurt am Main
-
Freiburg im Breisgau, Alemania, 79106
- Reclutamiento
- Universitätsklinikum Freiburg - Klinik für Frauenheilkunde
-
Contacto:
- Markus Hübner, Prof. Dr.
-
Greifswald, Alemania, 17475
- Reclutamiento
- Universitätsmedizin Greifswald
-
Contacto:
- Zaher Alwafai, Dr.
- Número de teléfono: +49 3834 86 6500
- Correo electrónico: zaher.alwafai@med.uni-greifswald.de
-
Höxter, Alemania, 37671
- Activo, no reclutando
- St. Ansgar Krankenhaus Höxter
-
Kiel, Alemania, 24105
- Activo, no reclutando
- Universitätsklinikum Kiel
-
Nuremberg, Alemania, 90419
- Activo, no reclutando
- Klinikum Nürnberg Nord / Klinik für Frauenheilkunde
-
Schwerin, Alemania, 19055
- Activo, no reclutando
- Helios Kliniken Schwerin
-
Tübingen, Alemania, 72076
- Activo, no reclutando
- Universitätsklinikum Tübingen - Frauenklinik
-
-
Free and Hanseatic City of Hamburg
-
Hamburg, Free and Hanseatic City of Hamburg, Alemania, 22457
- Activo, no reclutando
- Albertinen Krankenhaus Hamburg
-
-
Hesse
-
Wiesbaden, Hesse, Alemania, 65189
- Activo, no reclutando
- St. Josefs-Hospital Wiesbaden
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Patients with gynecological disease that may be treated by surgical intervention.
Descripción
Key Inclusion Criteria:
- Woman with 18 years of age or older
- Patient is willing to participate and to comply with the study procedures as demonstrated by signing the informed consent
- Patient is a candidate for a gynecological procedure to be performed with the Intuitive Surgical System
Key Exclusion Criteria:
- Life expectancy of less than 1 year
- Pregnancy, or positive pregnancy test for women prior to menopause or breastfeeding women
- Current participation in a clinical study, if not pre-approved by Intuitive
- Individuals who are unable to fully understand all aspects of the study that are relevant to the decision to participate (mentally or verbally), or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliation
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
da Vinci Patients
Consecutive enrollment of patients with indications of interest and having a da Vinci robotic-assisted surgery |
Robotic-assisted surgery (da Vinci) |
|
Epidemiological Data Audit
Extended data collection on patients with indications of interest, eligible for a robotic-assisted surgery, but treatment choice was not a da Vinci surgery |
Non-da Vinci Surgery |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of complications related to the surgery up to 30 days
Periodo de tiempo: 30 days
|
Describe the number of complications related to the surgery up to 30 days; adverse events as documented during the first 30 days will be classified as four different levels of causality to the surgery (not related, possible, probable and causal relationship). Descriptive analysis will be performed. |
30 days
|
|
Describe the number of patient-reported outcomes up to 12 months
Periodo de tiempo: 12 months
|
Describe the patient-reported outcomes up to 12 months; descriptive analysis will be performed on the data directly reported via the patients (patient questionnaires); information included are number of complications, re-hospitalizations, re-operations, disease recurrence, disease remission, new disease diagnosis and pain status including pain medication |
12 months
|
|
Characterize the treatment decision as reported by the treating physician
Periodo de tiempo: 30 days
|
Characterize the treatment decision per data provided by the treating physician (within the study database) including the rationale given for the treatment decision (e.g., age of the patient or co-morbidity); number of treatment decisions, e.g., for surgical therapy (open surgery or minimal-invasive therapy), watchful waiting, or treatment with medication will be described; descriptive analysis will be performed |
30 days
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Investigate the impact of patient characteristics on surgery
Periodo de tiempo: 30 days
|
Descriptive analysis of patient characteristics such as age on surgery (e.g., duration of surgery, instrument usage) |
30 days
|
|
Investigate the impact of patient characteristics on clinical outcome
Periodo de tiempo: 30 days
|
Descriptive analysis of patient characteristics such as age on clinical outcome (e.g., re-operation) |
30 days
|
|
Investigate the impact of patient characteristics on complications
Periodo de tiempo: 30 days
|
Descriptive analysis of patient characteristics such as age on complication (number of complications reported during and after the surgery) |
30 days
|
|
Describe the impact from surgery to the patient's quality of life and function
Periodo de tiempo: 12 months
|
Describe the impact from surgery to the patient's quality of life and function by comparing the baseline quality of life and functional status with the post-operative status (post-operative day 1-3, 30 days, 90 days, 6 months and 12 months) |
12 months
|
|
Describe the number of Intuitive instruments used per procedure and patient characteristics
Periodo de tiempo: 30 days
|
Describe the number of Intuitive instruments used per procedure and patient characteristics; descriptive analysis will be performed on the number of instruments used per specific procedure and patient |
30 days
|
|
Describe the number of disease recurrence and re-operation at final patient follow-up
Periodo de tiempo: 12 months
|
Describe the number disease recurrence and re-operation at final patient follow-up; descriptive analysis will be performed |
12 months
|
|
Describe the number of conversion per procedure and patient characteristics
Periodo de tiempo: 30 days
|
Describe the number conversion per procedure and patient characteristics; descriptive analysis will be performed |
30 days
|
|
Describe the impact of surgeon experience on surgical times (duration of surgery per treating surgeon)
Periodo de tiempo: 30 days
|
Describe the impact of surgeon experience on surgical times, descriptive analysis will be performed on the surgical times (duration of surgery) per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on clinical outcome (number of clinical outcomes per treating surgeon)
Periodo de tiempo: 30 days
|
Describe the impact of surgeon experience on clinical outcome; descriptive analysis will be performed, e.g., on number of re-operation or re-hospitalization per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on complications (number of events per surgeon)
Periodo de tiempo: 30 days
|
Describe the impact of surgeon experience on complications; descriptive analysis will be performed on number of adverse events per treating surgeon |
30 days
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Ingolf Juhasz-Böss, Prof. Dr., University Hospital Freiburg
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Enfermedades urogenitales
- Enfermedades Genitales
- Enfermedades urogenitales femeninas
- Enfermedades urogenitales femeninas y complicaciones del embarazo
- Enfermedades Genitales Femeninas
- Procedimientos quirúrgicos, operativo
- Tecnología, industria y agricultura
- Automatización
- Tecnología
- Cirugía, asistida por computadora
- Robótica
- Procedimientos quirúrgicos robóticos
Otros números de identificación del estudio
- 114363C
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .